Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1989 Nov 11;299(6709):1187–1192. doi: 10.1136/bmj.299.6709.1187

Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

P H Held 1, S Yusuf 1, C D Furberg 1
PMCID: PMC1838102  PMID: 2513047

Abstract

OBJECTIVE--To assess the effects of calcium channel blockers on development of infarcts, reinfarction, and mortality. DESIGN--A systematic overview of all randomised trials of calcium channel blockers in myocardial infarction and unstable angina. PATIENTS--19,000 Patients in 28 randomised trials. RESULTS--In the trials of myocardial infarction 873 deaths occurred among 8870 patients randomised to active treatment compared with 825 deaths among 8889 control patients (odds ratio of 1.06, 95% confidence interval of 0.96 to 1.18). There was no evidence of a beneficial effect on development and size of infarcts or rate of reinfarction. The results were similar in short term trials in which treatment was confined to the acute phase and those in which treatment was started some weeks later and continued for a year or two. There was no evidence of heterogeneity among different calcium channel blockers in their effects on any end point. The results were similar in the unstable angina trials (110 out of 561 patients treated with calcium channel blocker compared with 104 out of 548 controls developed a myocardial infarction; 14 out of 591 treated compared with nine out of 578 controls died). CONCLUSIONS--Calcium channel blockers do not reduce the risk of initial or recurrent infarction or death when given routinely to patients with acute myocardial infarction or unstable angina.

Full text

PDF
1187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andre-Fouet X., Usdin J. P., Gayet C., Wilner C., Thizy J. F., Viallet M., Apoil E., Vernant P., Pont M. Comparison of short-term efficacy of diltiazem and propranolol in unstable angina at rest--a randomized trial in 70 patients. Eur Heart J. 1983 Oct;4(10):691–698. doi: 10.1093/oxfordjournals.eurheartj.a061380. [DOI] [PubMed] [Google Scholar]
  2. Branagan J. P., Walsh K., Kelly P., Collins W. C., McCafferty D., Walsh M. J. Effect of early treatment with nifedipine in suspected acute myocardial infarction. Eur Heart J. 1986 Oct;7(10):859–865. doi: 10.1093/oxfordjournals.eurheartj.a061972. [DOI] [PubMed] [Google Scholar]
  3. Bussmann W. D., Seher W., Gruengras M. Reduction of creatine kinase and creatine kinase-MB indexes of infarct size by intravenous verapamil. Am J Cardiol. 1984 Dec 1;54(10):1224–1230. doi: 10.1016/s0002-9149(84)80071-5. [DOI] [PubMed] [Google Scholar]
  4. Crea F., Deanfield J., Crean P., Sharom M., Davies G., Maseri A. Effects of verapamil in preventing early postinfarction angina and reinfarction. Am J Cardiol. 1985 Apr 1;55(8):900–904. doi: 10.1016/0002-9149(85)90714-3. [DOI] [PubMed] [Google Scholar]
  5. Eichler H. G., Mabin T. A., Commerford P. J., Lloyd E. A., Beck W., Opie L. H. Tiapamil, a new calcium antagonist: hemodynamic effects in patients with acute myocardial infarction. Circulation. 1985 Apr;71(4):779–786. doi: 10.1161/01.cir.71.4.779. [DOI] [PubMed] [Google Scholar]
  6. Eisenberg P. R., Lee R. G., Biello D. R., Geltman E. M., Jaffe A. S. Chest pain after nontransmural infarction: the absence of remediable coronary vasospasm. Am Heart J. 1985 Sep;110(3):515–521. doi: 10.1016/0002-8703(85)90068-7. [DOI] [PubMed] [Google Scholar]
  7. Erbel R., Pop T., Meinertz T., Olshausen K. V., Treese N., Henrichs K. J., Schuster C. J., Rupprecht H. J., Schlürmann W., Meyer J. Combination of calcium channel blocker and thrombolytic therapy in acute myocardial infarction. Am Heart J. 1988 Mar;115(3):529–538. doi: 10.1016/0002-8703(88)90800-9. [DOI] [PubMed] [Google Scholar]
  8. Gerstenblith G., Ouyang P., Achuff S. C., Bulkley B. H., Becker L. C., Mellits E. D., Baughman K. L., Weiss J. L., Flaherty J. T., Kallman C. H. Nifedipine in unstable angina: a double-blind, randomized trial. N Engl J Med. 1982 Apr 15;306(15):885–889. doi: 10.1056/NEJM198204153061501. [DOI] [PubMed] [Google Scholar]
  9. Gibson R. S., Boden W. E., Theroux P., Strauss H. D., Pratt C. M., Gheorghiade M., Capone R. J., Crawford M. H., Schlant R. C., Kleiger R. E. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial. N Engl J Med. 1986 Aug 14;315(7):423–429. doi: 10.1056/NEJM198608143150704. [DOI] [PubMed] [Google Scholar]
  10. Gordon G. D., Mabin T. A., Isaacs S., Lloyd E. A., Eichler H. G., Opie L. H. Hemodynamic effects of sublingual nifedipine in acute myocardial infarction. Am J Cardiol. 1984 May 1;53(9):1228–1232. doi: 10.1016/0002-9149(84)90069-9. [DOI] [PubMed] [Google Scholar]
  11. Gottlieb S. O., Becker L. C., Weiss J. L., Shapiro E. P., Chandra N. C., Flaherty J. T., Gottlieb S. H., Ouyang P., Mellits E. D., Townsend S. N. Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial. Br Heart J. 1988 Apr;59(4):411–418. doi: 10.1136/hrt.59.4.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hlatky M. A., Cotugno H. E., Mark D. B., O'Connor C., Califf R. M., Pryor D. B. Trends in physician management of uncomplicated acute myocardial infarction, 1970 to 1987. Am J Cardiol. 1988 Mar 1;61(8):515–518. doi: 10.1016/0002-9149(88)90756-4. [DOI] [PubMed] [Google Scholar]
  13. Hugenholtz P. G., Serruys P. W., Fleckenstein A., Nayler W. Why Ca2+ antagonists will be most useful before or during early myocardial ischaemia and not after infarction has been established. Eur Heart J. 1986 Apr;7(4):270–278. doi: 10.1093/oxfordjournals.eurheartj.a062064. [DOI] [PubMed] [Google Scholar]
  14. Jaffe A. S., Biello D. R., Sobel B. E., Geltman E. M. Enhancement of metabolism of jeopardized myocardium by nifedipine. Int J Cardiol. 1987 Apr;15(1):77–89. doi: 10.1016/0167-5273(87)90294-4. [DOI] [PubMed] [Google Scholar]
  15. Loogna E., Sylvén C., Groth T., Mogensen L. Complexity of enzyme release during acute myocardial infarction in a controlled study with early nifedipine treatment. Eur Heart J. 1985 Feb;6(2):114–119. doi: 10.1093/oxfordjournals.eurheartj.a061824. [DOI] [PubMed] [Google Scholar]
  16. Mehta J., Pepine C. J., Day M., Guerrero J. R., Conti C. R. Short-term efficacy of oral verapamil in rest angina. A double-blind placebo controlled trial in CCU patients. Am J Med. 1981 Dec;71(6):977–982. doi: 10.1016/0002-9343(81)90323-5. [DOI] [PubMed] [Google Scholar]
  17. Muller J. E., Morrison J., Stone P. H., Rude R. E., Rosner B., Roberts R., Pearle D. L., Turi Z. G., Schneider J. F., Serfas D. H. Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison. Circulation. 1984 Apr;69(4):740–747. doi: 10.1161/01.cir.69.4.740. [DOI] [PubMed] [Google Scholar]
  18. Muller J. E., Turi Z. G., Pearle D. L., Schneider J. F., Serfas D. H., Morrison J., Stone P. H., Rude R. E., Rosner B., Sobel B. E. Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation. 1984 Apr;69(4):728–739. doi: 10.1161/01.cir.69.4.728. [DOI] [PubMed] [Google Scholar]
  19. Opie L. H., Buhler F. R., Fleckenstein A., Hansson L., Harrison D. C., Poole-Wilson P. A., Schwartz A., Vanhoutte P. M., Braunwald E., Nayler W. G. International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease. Am J Cardiol. 1987 Sep 1;60(7):630–632. doi: 10.1016/0002-9149(87)90318-3. [DOI] [PubMed] [Google Scholar]
  20. Parodi O., Maseri A., Simonetti I. Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. Br Heart J. 1979 Feb;41(2):167–174. doi: 10.1136/hrt.41.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Salerno D. M., Asinger R. W., Elsperger J., Ruiz E., Hodges M. Frequency of hypokalemia after successfully resuscitated out-of-hospital cardiac arrest compared with that in transmural acute myocardial infarction. Am J Cardiol. 1987 Jan 1;59(1):84–88. doi: 10.1016/s0002-9149(87)80075-9. [DOI] [PubMed] [Google Scholar]
  22. Sirnes P. A., Overskeid K., Pedersen T. R., Bathen J., Drivenes A., Frøland G. S., Kjekshus J. K., Landmark K., Rokseth R., Sirnes K. E. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial. Circulation. 1984 Oct;70(4):638–644. doi: 10.1161/01.cir.70.4.638. [DOI] [PubMed] [Google Scholar]
  23. Thuesen L., Jørgensen J. R., Kvistgaard H. J., Sørensen J. A., Vaeth M., Jensen E. B., Jensen J. J., Hagerup L. Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial. Br Med J (Clin Res Ed) 1983 Apr 2;286(6371):1107–1108. doi: 10.1136/bmj.286.6371.1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Théroux P., Taeymans Y., Morissette D., Bosch X., Pelletier G. B., Waters D. D. A randomized study comparing propranolol and diltiazem in the treatment of unstable angina. J Am Coll Cardiol. 1985 Mar;5(3):717–722. doi: 10.1016/s0735-1097(85)80400-9. [DOI] [PubMed] [Google Scholar]
  25. Walker L. J., MacKenzie G., Adgey A. A. Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction. Br Heart J. 1988 Apr;59(4):403–410. doi: 10.1136/hrt.59.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wilcox R. G., Hampton J. R., Banks D. C., Birkhead J. S., Brooksby I. A., Burns-Cox C. J., Hayes M. J., Joy M. D., Malcolm A. D., Mather H. G. Trial of early nifedipine in acute myocardial infarction: the Trent study. Br Med J (Clin Res Ed) 1986 Nov 8;293(6556):1204–1208. doi: 10.1136/bmj.293.6556.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985 Mar-Apr;27(5):335–371. doi: 10.1016/s0033-0620(85)80003-7. [DOI] [PubMed] [Google Scholar]
  28. Zannad F., Amor M., Karcher G., Maurin P., Ethevenot G., Sebag C., Bertrand A., Pernot C., Gilgenkrantz J. M. Effect of diltiazem on myocardial infarct size estimated by enzyme release, serial thallium-201 single-photon emission computed tomography and radionuclide angiography. Am J Cardiol. 1988 Jun 1;61(15):1172–1177. doi: 10.1016/0002-9149(88)91149-6. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES